Approval · Notice of Compliance 17866 · 2016
XTORO: Notice of Compliance 17866
Issued March 11, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17866
- Date
- March 11, 2016
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XTORO | 02452928 | Approved |
Medicinal ingredients
- FINAFLOXACIN 0.3 PER